Docusate Sodium
Product Images NDC 10544-130

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 10544-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg 20ct (Label Docusate Sodium Caps 100mg Bpi(10544 130 20) Sda(66424 030 10) Rev1)

This is a description of a medication, Docusate Sodium (Stool Softener) in softgel capsule form. The packaging contains 20 capsules with 100mg content per capsule. It has an NDC code of 10544-130-20 and LCM 00. The manufacturer is DA Laboratories, Inc with a Revision number of 1 while the repackager is Blenheim Pharmacal Inc. The capsules are meant to reduce nausea, constipation and difficulty in bowel movement. Lot number and expiration date differs with each caption. Information on dosage, usage, and administration is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.